This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

United Health Products, Inc.: Epic Wound Care Inc.'s HemoStyp™ Listed By Industry Publication Among The "Best Products Evaluated During 2012"; United Health Products Adds New Member To Board Of Directors

United Health Products, Inc. (OTCQB: UEEC.PK) and its wholly owned subsidiary, Epic Wound Care, Inc., which develops and markets products and technologies in the healthcare sector, today announced that Epic Wound Care's hemostatic gauze, which is registered and branded in the USA under the trademark HemoStyp™, has been featured in the Clinicians Report ® for the second time this year. The report is a published scientific testimonial that features products which have met the criteria and approval of the dental community. The Clinicians Report ® is a 35-year-old industry publication serving as an informative tool to the dental industry with distribution to over 10,000 dental care providers. It features new products with published test results that have been tested and approved by dentists and the dental community. In the December issue HemoStyp™ was listed among the "Best Products Evaluated During 2012" with 83% of the evaluators stating that they would recommend the product. Dr. Phillip Forman, CEO of United Health Products Inc., stated that the "continued recognition from the Clinicians Report ® validates the HemoStyp™ gauze and the use of the product in the dental industry." Dr. Forman went on to say that "as a result of the prior report the company has received an initial order from one of the dental industry’s largest dental products distributors" and believes that "this new report generates the same kind of interest in the product." The Clinicians Report ® December Edition can been viewed at the following link for a nominal fee –

United Health Products, Inc. also announced the addition of Nate Knight to its Board of Directors. Mr. Knight brings to the company years of business experience and knowledge of the Company's HemoStyp™ product. Nate was a principal in Med Spring, Inc., the company that originally developed the HemoStyp™ gauze product, later acquired by United Health Products, Inc. Mr. Knight, age 64, has been a public accountant for over 30 years, has owned and operated his own accounting business, has previously held a Series 7 license, and is currently employed as an internal auditor with Prime Alliance Bank. Dr. Forman stated, "Mr. Knight, with his years of accounting experience and particular knowledge of the product as well as its potential applications, is a welcome addition to the Board of Directors."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs